School of Medicine
Showing 11-20 of 60 Results
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Hannah graduated from Kansas City University of Medicine & Biosciences. He then completed a residency in Internal Medicine at the University of Kansas and a fellowship in Hospice & Palliative Medicine at Stanford University before joining as faculty at Stanford. His clinical practice includes both inpatient palliative care consultation as well as ambulatory care in palliative medicine. His research and educational interests include symptom management and utilizing media to grow palliative care services and education.
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Stephanie Harman is a palliative care physician and Clinical Associate Professor of Medicine. She graduated from Case Western Reserve University School of Medicine and went on to complete a residency in Internal Medicine at Stanford and a Palliative Care fellowship at the Palo Alto VA/Stanford program. She then joined the faculty at Stanford. She co-founded the Palliative Care Program at Stanford Health Care in 2007 and serves as the Clinical Chief of the Section of Palliative Care in the Division of Primary Care and Population Health. She is the inaugural Associate Chair for Women in Medicine for the Department of Medicine and the co-director of the Stanford Leadership Development Program, a joint program between Stanford Health Care and the School of Medicine. A 2017 Cambia Health Foundation Sojourns Scholar Leader Awardee, she has a passion for leadership development and has built a Women’s Leadership in Academic Medicine (WLAM) program in the PCPH Division, which is now in its 4th year with 28 women leaders. Her other professional interests include clinical ethics in decision-making and serious illness communication skills training.
Arthur L. Bloomfield Professor of Medicine and Professor, by courtesy, of Health Policy
BioDr. Robert A. Harrington is an interventional cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chairman of the Department of Medicine at Stanford University. Dr. Harrington was previously the Richard Sean Stack, MD Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes, building local, national and international collaborations for the efficient conduct of innovative clinical research and trying to better understand and improve upon the methodology of clinical research. His research has been extensively funded through NIH, NIA, other peer reviewed agencies and private industry. Committed to training and mentorship, Harrington has served as the principal mentor for more than 20 post-doctoral clinical research fellows focused on cardiovascular research.
He has authored more than 640 peer-reviewed manuscripts, reviews, book chapters, and editorials. Thomson Reuters lists him as one of the most cited investigators in clinical medicine from 2002-2014. He is a deputy editor of JAMA Cardiology and an editorial board member for the Journal of the American College of Cardiology. He has served as editor of five textbooks and is a senior editor of the 13th and 14th editions of Hurst’s The Heart, one of the leading textbooks of cardiovascular medicine. He has been a member of the NHLBI’s Clinical Trials Study Section and the IOM’s Working Group on Data Sharing. He served as a member of the NIH NCATS Advisory Council Working Group on the IOM CTSA Program. He recently served a second term as a member and the chair of the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.
Harrington was recently a member of the American College of Cardiology (ACC) Board of Trustees and is currently a member of the American Heart Association’s (AHA) Board of Directors, its Science Advisory and Coordinating Committee, and its President-elect. He will serve as the AHA President beginning in July 2019. He served as the Chair for the AHA’s Scientific Sessions in 2013 and 2014. Harrington is a Fellow of the American College of Cardiology, the American Heart Association, the Society for Cardiac Angiography and Intervention, the European Society of Cardiology, the American College of Chest Physicians and the American College of Physicians. He is an elected member of the Association of American Physicians and the Association of University Cardiologists. In 2015, he was elected to membership in the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology. He was awarded the AHA's Clinical Research Prize in 2017.
Harrington received his BA in English at the College of the Holy Cross, Worcester, MA. He attended Dartmouth Medical School and received his MD from Tufts University School of Medicine, Boston MA. He did his internship, residency and served as the chief resident in internal medicine at the University of Massachusetts Medical Center, Worcester MA. He trained in cardiology, interventional cardiology and clinical research (Duke Databank for Cardiovascular Disease) at Duke University Medical Center, Durham NC where he was a faculty member from 1993-2012 before joining the Stanford University faculty in 2012. Interested in innovative learning tools, including novel methods of communicating scientific information, Harrington hosts a regular podcast on theheart.org, The Bob Harrington Show, and can be followed on Twitter @HeartBobH.
Professor (Research) of Medicine, Emeritus
Current Research and Scholarly InterestsMy major research interests and activities over the next several years will focus on the development and evaluation of the objective measurement of physical activity in free-living populations using a variety of sensing devices and mobile phones for data collection and processing. Also, I will continue to direct the Stanford Heart Network with the major mission being to assist community-based CVD prevention/treatment programs implement more effective heart attack and stroke prevention programs.
Michelle Hauser, MD, MS, MPA, FACP, FACLM
Clinical Associate Professor, Surgery - General Surgery
Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsPrimary care physician, prevention researcher, medical educator and classically-trained chef who combines these fields to move people away from diets that lead to chronic disease and toward eating delicious food that promotes health and well-being.
Assistant Professor (Research) of Neurology and of Medicine (BMIR)
Current Research and Scholarly InterestsStatistical genetics and other omics to study Alzheimer's disease.
Associate Professor (Teaching) of Psychology and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsEnhancing our understanding of psychosocial factors at work (occupational stress, social support at work, organizational justice, organizational empowerment) that are associated with health and disease.
Developing effective strategies for enhancing employee resiliency and reducing exposure to psychological and behavioral risk factors at work.
Gregory M. Heestand, MD
Clinical Associate Professor, Medicine - Oncology
BioDr. Heestand is a board-certified medical oncologist with a focus on gastrointestinal cancers, primarily hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. He currently serves as the medical oncology champion of the Stanford Hepatobiliary Tumor Board, as well as the principal investigator of multiple clinical trials. He also collaborates with campus laboratories to help develop new biomarker and treatment technologies. Dr. Heestand is a member of the ECOG-ACRIN gastrointestinal committee and serves as a representative to the NCI Hepatobiliary Task Force. He is also the director of the Stanford Medical Oncology Fellowship Program.
Dr. Heestand and his team take great pride in helping patients and their families face gastrointestinal cancer.
Outside of the clinic, Dr. Heestand enjoys playing the piano, teaching his kids about music, cooking for friends and family, and surfing the internet for interesting things to read.
Shireen N. Heidari
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioShireen Heidari, MD is a palliative care and family medicine physician. She works as part of the inpatient palliative care consult team providing complex symptom management and support for patients and families facing any stage of a serious illness. Dr. Heidari is the program director for the Stanford University Hospice and Palliative Fellowship. From 2018-2022 she served as the rotation director for students, residents and fellows on the Stanford inpatient palliative consult service. Dr. Heidari was also the clinical lead for the Stanford site of the PERIOP-PC Study, which involved collaboration with the surgical department to evaluate the impact of surgeon-palliative care team co-management for patients and family members preparing for major upper gastrointestinal cancer surgery.
Before moving to northern California, Dr. Heidari attended medical school at Boston University, completed her residency at UC San Diego where she served as chief resident, followed by palliative fellowship at UCLA. Her interests include early palliative care integration, narrative medicine, and expanding primary palliative care skills for all clinicians. Outside of her clinical and mentorship work, she is likely writing creatively or outside chasing her border collie.
Paul Heidenreich, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy research interests include
1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.
2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.
3) Outcomes research using existing clinical and administrative datasets.
4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).